The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 17:310-323, August 2005
doi: 10.1176/appi.neuropsych.17.3.310
© 2005 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Veazey, C.
* Articles by Kunik, M. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Veazey, C.
* Articles by Kunik, M. E.
Related Collections
* Depression
* Parkinson's Disease

Special Article

Prevalence and Treatment of Depression in Parkinson’s Disease

Connie Veazey, Ph.D., Sahinde Ozlem Erden Aki, M.D., Karon F. Cook, Ph.D., Eugene C. Lai, M.D., Ph.D. and Mark E. Kunik, M.D., MPH

Received September 12, 2003; revised January 21, 2004; accepted April 5, 2004. From the Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, VA Medical Center, Houston, Texas; the Houston Veterans Affairs Parkinson’s Disease Research, Education, and Clinical Center, Houston, Texas; Baylor College of Medicine, Department of Neurology, Houston, Texas; Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, Houston, Texas; the South Central Mental Illness Research, Education, & Clinical Center (MIRECC). Address correspondence to Dr. Kunik, Houston Center for Quality of Care and Utilization Studies, Veterans Affairs Medical Center (152), 2002 Holcombe Blvd., Houston, TX 77030; mkunik{at}bcm.tmc.edu (E-mail).

Parkinson’s disease (PD) is a progressive neurological condition with debilitating symptoms, and depression is a common comorbid condition of this disease. The authors review existing literature on the prevalence and treatment of depression in PD. Prevalence estimates of depression vary widely, ranging from 7%–76%. This variation is due to inconsistent methodology. Treatment options for depression in PD include medication therapy, electroconvulsive therapy (ECT), and psychotherapy. There are few randomized controlled trials of these treatment options. The authors argue for more systematic and controlled research examining both the prevalence and treatment of depression in PD.

Key Words: Parkinson’s Disease • Depression • Prevalence




This article has been cited by other articles:


Home page
NeurologyHome page
I. H. Richard
Apathy does not equal depression in Parkinson disease: Why we should care.
Neurology, July 11, 2006; 67(1): 10 - 11.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org